EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene

Leon Kircik, Neal Bhatia, Edward Lain, Abby Jacobson

Journal of Drugs in Dermatology · 2023

DOI: 10.36849/jdd.7399 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Leon Kircik und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Propionates, Psoriasis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropionatesPsoriasisHumansSteroidsExcipientsNicotinic AcidsRetinoidsClobetasol

Substanzen

PropionatesSteroidsExcipientstazaroteneNicotinic AcidsRetinoidshalobetasolClobetasol

Zitieren

APA

Kircik, L., Bhatia, N., Lain, E., & Jacobson, A. (2023). Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7399

Vancouver

Kircik L, Bhatia N, Lain E, Jacobson A. Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7399

BibTeX
@article{Kircik2023,
  author = {Kircik, Leon and Bhatia, Neal and Lain, Edward and Jacobson, Abby},
  title = {Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene},
  journal = {Journal of Drugs in Dermatology},
  year = {2023},
  doi = {10.36849/jdd.7399}
}
Kostenlos starten →